Chen Xue-Hong, Miao Yuan-Xin, Wang Xiao-Ji, Yu Zhuang, Geng Mei-Yu, Han Yan-Tao, Wang Le-Xin
Department of Molecular Pharmacology, Marine Drug and Food Institute, Ocean University of China, Qingdao, China.
Cell Physiol Biochem. 2011;27(3-4):227-32. doi: 10.1159/000327948. Epub 2011 Apr 1.
To investigate the effect of Ginkgo biloba extract (EGb761) on cell proliferation and apoptosis in human colon cancer cells.
Human colon cancer cell lines (HT-29) were cultured and incubated with various concentrations (0-320 mg/l) of EGb 761 solution for up to 72 h. Cell viability, cell apoptosis, cell cycle, expression of caspase-3, the mRNA levels of p53, and Bcl-2 were assessed.
EGb 761 inhibited the growth of HT-29 cells in a time-dose-dependent manner. At 80 and 320 mg/L, EGb 761 increased the number of cells in the G0/G1 phase and reduced cells in the G2/M and S phase. EGb 761 treatment also increased the apoptosis ratio of the HT-29 cells. EGb 761 treatment was associated with an increase in caspase-3 activities, reduction in bcl-2 mRNA expression and elevation in p53 mRNA expression.
EGb 761 inhibits the progression of human colon cancer cells. Its therapeutic effect may be related to enhanced caspase-3 activities, up-regulation of p53 and down-regulation of bcl-2 genes.
